ページ2 - 最高のPET-CT検査医師 - トップ70名の医師

この医師は1998年にイスタンブール大学のÇapa医学部を卒業し、2002年にCerrahpaşa医学部で放射線診断学およびインターベンショナルラジオロジーの研修を修了しました。診断放射線学とテレラジオロジー、さらにインターベンショナルラジオロジーを専門としており、12の国内および1つの国際会議に参加し、多数の口頭および書面発表を行っています。この医師はHisar Intercontinental Hospital、Merzifon Air Hospital、Istanbul Emar Center、Haseki Training and Research Hospitalで職務を務めてきました。

Dr. Rahib Hasanov is a medical oncologist. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine (1999–2005). He completed an internal medicine residency (2009–2013) and a medical oncology fellowship at Marmara University (2015–2018). He also completed an observership at Houston Methodist Hospital (2006–2007).

He focuses on personalized oncology. His treatments include immunotherapy, targeted therapy, and novel agents. His clinical interests include gastrointestinal, breast, lung, and genitourinary cancers.

He attends national and international conferences. He welcomes patients from Turkey, Azerbaijan, Montenegro, Georgia, Uzbekistan, the Middle East, Europe, and the United States.

Şeref Kömürcü教授は、ECFMGおよびESMO認定の医療および乳腺腫瘍学者であり、トルコを拠点に20年以上の実践経験を持っています。硬癌、乳癌、大腸癌、肺癌の治療を専門としています。

職歴

• 2016年から — アナドル医療センターでの医療腫瘍学専門家

学歴

• 1986年 — ギュルハネ軍医学校 — 一般医学の学位
• 1993年 — ギュルハネ軍医学校 — 内科専門
• 1993年 — ECFMG（米国）証明書取得
• 1996年 — ギュルハネ軍医学校 — 医療腫瘍学専門
• 1999年 — ESMO医療腫瘍学証明書取得（ヨーロッパ）。

教育活動

• 2011-2016年 — ギュルハネ軍医学校の医療腫瘍学部で教授
• 1999-2011年 — ギュルハネ軍医学校の医療腫瘍学部で准教授。

受賞

• 2003年 — GATA教育および教育の成功賞
• 2009年 — GATA卓越したサービス賞。

科学活動

癌管理に関する110を超える論文を書いています。

会員

• アメリカ臨床腫瘍学会
• ヨーロッパ医療腫瘍学会
• 多国籍癌支持療法協会
• トルコ腫瘍グループ
• トルコ医療腫瘍機構
• 肺癌機構
• 医療コミュニケーション機構
• 乳房疾患協会。

Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.

Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.

クリストフ・C・ツィーリンスキー教授は、オーストリアで最も著名な腫瘍専門医の一人であり、医療腫瘍学、血液学、がん免疫療法の分野で世界的に著名なリーダーです。過去40年間にわたり、彼はオーストリアそして国際的に現代のがん治療の発展を形成し、最先端の研究を思いやりのある、個別化された患者ケアと組み合わせてきました。

彼はウィーン大学で医学を学び、そこで1970年代に医学博士号を取得し、その後、内科、血液学、腫瘍学のトレーニングを受けました。専門分野を修了した後、彼はウィーン医科大学でその学術的キャリアを開始し、後にそこでは教授となり、腫瘍科の主任となりました。

     1980年代 – 内科と腫瘍学で専門的なトレーニングを完了し、ウィーン総合病院（AKH）で臨床と研究の仕事を始めました。

     1990年代 – ウィーン医科大学およびウィーン総合病院で腫瘍内科クリニカルディビジョンの責任者に任命され、オーストリアで最大の腫瘍学部門を率いました。

     2000年代 – ウィーン包括がんセンター（CCC）を設立し運営し、患者ケア、研究、教育を統合した多分野の機関です。

     2010年代 – 中欧協力腫瘍学グループ（CECOG）の会長を務め、国際臨床試験の調整を行い、ヨーロッパのがんセンター間の協力を促進しました。

     現在 – ウィーンがんセンターの議長およびウィーナー・プライヴァートクリニック国際オンコロジーセンターの医療部長として、個別化医療と免疫腫瘍学の取り組みを主導しています。

ツィーリンスキー教授は、世界の主要ながん学会で広く出版され、個別化がん治療の開発に貢献し、各患者の腫瘍生物学に合わせた治療を行っています。彼は多くの国際会議で非常に求められる講演者であり、科学的および人道的寄与に対して数多くの賞を受賞しています。

彼のキャリアを通じて、ツィーリンスキー教授は、科学と共感の架け橋となることに尽力しており、患者が最も先進的な治療を受けるだけでなく、本当に優れた医学を定義する人間的ケアを受けられるようにしています。

ケイル教授は2004年にジュリアス・マクシミリアン大学ヴュルツブルクで医学の学位を取得し、優秀な成績で卒業しました。

彼の専門的なキャリアはハンブルクで始まり、そこで彼は初期の経験を積み、ハンブルク・アルトンクリニックの放射線科で博士論文を見事に防衛しました。当時はドイツやヨーロッパで最も進んだ放射線学センターの一つでした。 

2006年、ケイル教授はアーヘン大学病院に移り、著名なロルフ・W・ギュンター教授の指導の下で知識とスキルを深めました。

ギュンター教授のチームに所属し、その後クリニックディレクターであるクリスチャン・K・クール教授の指導の下、セバスチャン・ケイル教授は超音波やCT、MRIのような現代的なイメージング技術を使用し、複雑な医療介入を成功裏に行いました。

 2010年には、診断および介入放射線学クリニックの主要医師に任命され、2016年から2022年までクール教授が指導するクリニックの主要医師を務めました。

2022年以降、ケイル教授はソリンゲン学術病院の診断及び介入放射線クリニックの主任医師を務めています。

専門分野:

• 断面画像診断: 体全体の領域と病態のMRIとCT
• 介入放射線学サービスのフルレンジ
• 超音波検査、X線診断および蛍光透視
• 乳房診断

フォックス・ヴィオラ博士は、BKZゾーリンゲン血液腫瘍科・緩和医療科の主任医師です。同クリニックは、認定された集学的腫瘍センターです。フォックス博士は、ドイツおよびヨーロッパにおける腫瘍性疾患の薬物療法の第一人者であり、15年以上の臨床経験を有しています。

同博士は、ドイツ腫瘍学・血液腫瘍学会（GDHO）、ドイツ医師会、およびアメリカがん研究学会に所属しています。また、分子生物学の研究にも従事しており、その研究成果はがん治療および分子診断の発展に貢献しています。

主な専門領域は、化学療法、免疫療法、分子標的療法、および放射線療法です。フォックス博士は、革新的な治療法と患者への細やかな配慮で知られています。その取り組みにより、高い治癒率を達成し、同僚からの高い評価を得ています。

この医師は、肝臓、肺、前立腺、胃、副腎、副腎皮質、乳房、食道のがん、および腹膜中皮腫を含むさまざまながんの診断を専門としています。この医師は、医学教育と研究への貢献により、研究発表に対する功労証明書や、肝移植候補者における門脈血栓症の研究に対するMagna Cum Laudaなど、数々の賞を受賞しています。また、この医師は、European Society of Gastrointestinal and Abdominal RadiologyやRadiological Society of North Americaなど、いくつかの著名な学会の会員でもあります。

この医師は40年の経験を持つ核医学の専門家であり、ハイブリッドイメージング、腫瘍イメージング、分子乳房イメージングに焦点を当てています。この医師はSourasky Medical Centerで勤務しており、Rambam Medical Centerから核医学の専門資格を持っています。<\/p>

この医師はテルアビブ大学のSackler医学部からMDを取得し、イスラエル工科大学（Technion）からPhDを取得しており、カナダのダルハウジー大学で追加の研究を完了しています。<\/p>

Univ. Prof. Dr. ウォルフガング・ケストラーは、オーストリアの著名な医学的腫瘍学者および内科医であり、乳がん、婦人科悪性腫瘍、および標的がん治療の専門知識で国際的に認められています。臨床、学術、研究の経験が20年以上にわたり、彼はオーストリアにおける個別化がん治療の最前線の権威の一人となりました。

彼はウィーン大学で医学を学び、1990年代に卒業し、その後ウィーン医科大学で内科および医学的腫瘍学のレジデンシーを修了しました。キャリアの初期には、彼は先進的な腫瘍学者と共に標的療法と個別化医療の開発に従事し、これは後の彼の多くの研究に影響を与える分野となりました。

   1990年代 – ウィーン総合病院（AKH）での内科および腫瘍学の研究およびレジデンシーを修了しました。

   2000年代 – 固形腫瘍腫瘍学に特化し、乳がんや婦人科がんに焦点を当て、標的療法に関する初期の臨床試験に貢献しました。

   2010年代 – ウィーン医科大学の准教授および腫瘍学の臨床部門の副主任に任命され、分子腫瘍学の推進に貢献しました。

   現在 – ウィーン私立クリニックで上級コンサルタントとして勤務し、ウィーン医科大学での学術活動を続け、個別化された全身がん治療、免疫療法、および転位がん研究に注力しています。

ケストラー教授の研究関心には、バイオマーカーの開発、腫瘍生物学、および標的薬剤への耐性メカニズムが含まれており、正確な腫瘍学における新しい治療戦略の設計に貢献しています。彼の科学研究は主要な国際雑誌に掲載されており、彼はヨーロッパの腫瘍学ネットワークに積極的に参加し続けています。

診断の正確さ、臨床的共感、革新的な考え方で知られるケストラー教授は、科学的進歩と慈悲深い患者ケアを組み合わせた個別化がん医学の未来を体現しています。

Education

• 1986-1989, Bursa High School, Bursa, Turkey
• 1989-1995, Istanbul University, Istanbul School of Medicine, Turkey
• 1999-2003, (Residency) Kadir Has University, School of Medicine, Department of Radiation Oncology, Istanbul, Turkey
• 2015, (Associate Professor) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2021, (Professor) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2024, Istanbul Medipol University, Department of Radiation Oncology, Istanbul, Turkey

Experience

• 1995-1999, Şişli Florence Nightingale Hospital, Istanbul, Cardiology Department
• 2003, Gayrettepe Florence Nightingale Hospital, Istanbul, Department of Radiation Oncology
• 2015, (Associate Professor in Radiation Oncology) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2021, (Professor in Radiation Oncology) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2024, Istanbul Medipol University, Department of Radiation Oncology, Istanbul, Turkey

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.

Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

EDUCATION:

2000 - SSK Okmeydanı Training and Research Hospital, .

1996 - Istanbul University, Istanbul Faculty of Medicine

EXPERIENCE:

2019 - Istanbul Medipol University Pendik Hospital

2017 - 2019 - Private Adatıp Kurtköy Hospital

2005 - 2017 - Private Avicenna Umut Hospital

2003 - 2005 - SSK Yalova Regional Hospital

2002 - 2003 - Kayseri Military Hospital

EDUCATIONAL BACKGROUND

Medical Specialization YÜZÜNCÜ YIL UNIVERSITY

FACULTY OF MEDICINE/DEPARTMENT OF INTERNAL MEDICINE/DEPARTMENT OF PEDIATRICS

2/Feb/2009

Name of Thesis: Screening for hematuria and proteinuria in school age children (2008) Supervisor:(ŞÜKRÜ ARSLAN)

Undergraduate Education   SELÇUK UNIVERSITY

1997                      MERAM FACULTY OF MEDICINE /MERAM MEDICAL PRACTICE.

30/June/ 2003

Academic Duties

PROFESSOR           ISTANBUL MEDIPOL UNIVERSITY / FACULTY OF MEDICINE / DEPARTMENT OF INTERNAL MEDICAL SCIENCES 

2019

/ DEPARTMENT OF PEDIATRIC HEALTH AND DISEASES)

ASSOCIATE PROFESSOR    MEDIPOL UNIVERSITY / FACULTY OF MEDICINE / DEPARTMENT OF INTERNAL MEDICAL SCIENCES 

2014/-2019

/ DEPARTMENT OF PEDIATRIC HEALTH AND DISEASES)

ASSOCIATE PROFESSOR DÜZCE UNIVERSITY/FACULTY OF MEDICINE

2014/-2014

FACULTY MEMBER        DUZCE UNIVERSITY/FACULTY OF MEDICINE/DEPARTMENT OF INTERNAL 

2010/-2013

Supervised Theses 
Medical Specialization 
2022

MEDICAL SCIENCES/DEPARTMENT OF PEDIATRIC HEALTH AND DISEASES)

1. ATABAY CEM, (2022).  Determination of the frequency of adenotonsillar hypertrophy and serous otitis and their surgical prognosis in pediatric allergic rhinitis cases, Istanbul Medipol University->Faculty of Medicine->Department of Pediatric Health and Diseases (Completed)

Cemalettin Güne , (2013). Investigation of Bone Metabolism Changes in Children with Type 1 Diabetes Mellitus, 

1. DUZCE UNIVERSITY/FACULTY OF MEDICINE/DEPARTMENT OF INTERNAL MEDICAL SCIENCES/

DEPARTMENT OF CHILD HEALTH AND DISEASES/

Administrative Duties:

Chief Physician  ISTANBUL MEDIPOL UNIVERSITY/HEALTHCARE PRACTICE AND RESEARCH CENTER

2021

Works

Articles published in international peer-reviewed journals:

•  
• - CÖMERT   MURAT,Akgun  Cihangir,AKGÜN   AY  E  SERAP,OKUR   MESUT,GÜNDÜZ   MEHMET,TEMEL HAYRETT N  (2020).  Demographic  Characteristics   of   the  School-age   Children   With  Voiding Dysfunction,  and  Diagnostic Role  of  Ultrasound per  se..    Asian Pacific  Journal  of Health  Sciences,   6(1), 1-9. 
•  
• - OKUR MESUT,Erbey  Fatih,Kaya  Avni,Güven Ay  e  (2020). Van  Gölü  havzas nda 0–18  ya   grubu çocuklarda  Sitomegalovirus,  Rubella ve  Toksoplazma  seroprevalans .   Konuralp   T p   Dergisi,   4(1), 13-16. 

1. GÜNDÜZ  MEHMET,OKAN  MEL HA   AKSOY,  ENG L  AHMET   ZEK ,TEMEL   HAYRETT N,CÖMERT MURAT,OKUR  MESUT (2019).  The  relationship of  argyrophilic   proteins  of   the   nuclear?organized regions  and atopic  dermatitis   in  children.   Experimental   Dermatology,   28(11),  1309-1312.   
2. OKUR   MESUT,ERÖZ  RECEP,Bekta    Mehmet   Selçuk,Gül en   Süleyman,BAHADIR   ANZEL,Türker Yasin,GÜNE   CEMALETT N   (2016).   THE  RELATIONSHIP   BETWEEN   CONGENITAL  HEART   DEFECTS AND  e-NOS GENE  IN  DOWN SYNDROME..    Genetic  counseling (Geneva,  Switzerland),  27(3), 285-    293. 
3. Okan Meliha Aksoy, GÜNDÜZ MEHMET,  OKUR  MESUT, Akgun  Cihangir,  ES N  KÜBRA  (2016). Does maternal diet affect infantile colic?.  JOURNAL OF MATERNAL-FETAL &amp; NEONATAL MEDICINE, 29(19)-3141., Doi: 10.3109/14767058.2015.1115011 
4. Aksoy  Okan  Meliha,Gunduz   Mehmet,OKUR   MESUT,Akgun  Cihangir,ES  N   KÜBRA  (2015).   Does maternal  diet affect  infantile  colic?. The  Journal  of Maternal-Fetal   Neonatal  Medicine, 29(19), 3139-3141. 
5. Kaya Avni,OKUR  MESUT,Sal  Ertan,Peker Erdal,Köstü  Murat,TUNCER  O  UZ,K r mi  Ercan  (2014). Comparison of Cerebral Oximeter  and  Pulse Oximeter  Values  in the  first  72 hours  in  Premature, Asphyctic and Healthy Newborns. West Indian Medical Journal 
6. Uzun     Hakan,Gözkaya     Serçin,Ye  ildal     Nuray,OKUR     MESUT,ARSLANO   LU    LKNUR,KOCABAY KENAN,  enses  Dursun Ali  (2014).   The Prevalence  of  Goiter and  Hypothyroidism  among School   Children 6 Years after  Introduction of  a  Mandatory Salt  Iodination  Program in  a  Severely Iodine- Deficient  Area  of the  West  Black Sea  Region  of Turkey.   Journal  of Tropical  Pediatrics,  60(4), 318- 321. 
7. Özkan   Aybars,OKUR  MESUT,KAYA   MURAT,Kaya   Ertu rul,Küçük   Adem,Erba     Mesut,Kutlucan Leyla,Sahan   Leyla  (2013).   Sedoanalgesia   in  pediatric   daily   surgery..   International   journal   of clinical and experimental medicine, 6(7), 576-82. 
8. OKUR   MESUT,Erbey    Fatih,Yazicio  lu   Özlem,Çelik    Ali,Tükenmez    Bar  ,SÜNNETÇ O  LU MAHMUT,Gassalo   lu Mithat,Acar  Mehmet  Nuri (2013).   H1N1  influenza A  virus  Related Pneumonia     and Respiratory Failure. Indian Journal of Virology, 24(1), 85-89. 
9. OKUR    MESUT,ARSLAN    ÜKRÜ,GÜVEN    AHMET   SAM ,TEMEL    HAYRETT N,Bekta    Mehmet Selçuk,ÜSTYOL  LOKMAN (2013).  Determination  of  underlying   causes   in  asymptomatic,   early-stage renal  diseases  by dipstick  test..   Medicinski glasnik  :  official publication  of  the Medical  Association        of Zenica-Doboj Canton, Bosnia and Herzegovina, 10(1), 55-8. 
10. ERÖZ   RECEP,OKUR  MESUT,Özkan   Aybars,Berik   Özgür,GÜNE  CEMALETT  N   (2012).   Does   higher NORs expression affect  the developmental  stages  of Down  syndrome  infants?. Genetic  counseling (Geneva, Switzerland), 23(2), 249-53. )
11. OKUR MESUT,Özen   Semiha   Fatma,KOCABAY   KENAN,Çam  Kamil,Özkan   Aybars,Uzun   Hakan  (2012). The  effect  of maximum  voided  volume on  response  to desmopressin  therapy  in children  with   enuresis.. Journal of Nippon Medical School = Nippon Ika  Daigaku  zasshi, 79(4),  255-8.  
12. Uzun   Hakan,Alagöz    Demet,OKUR    MESUT,Dikici    Bünyamin,KOCABAY    KENAN,  enses    Dursun Ali,Özkan  Aybars,KAYA MURAT  (2012).   Do gastrointestinal  and  respiratory signs  and  symptoms  correlate with the  severity  of gastroesophageal  reflux?.  BMC Gastroenterology,  12(1)  (

Articles published in international peer-reviewed journals:

1. OKUR MESUT,Rüzgar Hacer,Erbey Fatih,Kaya  Avni  (2012). The  evaluation  of children  with monosymptomatic  nocturnal  enuresis for  attention  deficit and  hyperactivity  disorder.  International  Journal of Psychiatry in Clinical Practice, 16(3), 229-232. 
2. OKUR MESUT,Erbey  Fatih,Bekta   Mehmet  Selçuk,Kaya   Avni,Do   an  Murat,Acar   Mehmet   Nuri,Uzun Hakan  (2012).  Retrospective   clinical   and  laboratory   evaluation   of  children   with   brucellosis. Pediatrics International, 54(2), 215-218. 

B Articles published in national peer-reviewed journals:

1. Kaya Avni,Erbey Fatih,OKUR  MESUT,Sal Ertan,ÜSTYOL  LOKMAN,Bekta  Mehmet Selçuk  (2020).  Van Yöresinde 0-18  Ya  lar  Aras  ndaki  ÇocuklardaHepatit  B Virusu  Seropozitifli   i ve  A   lanma Durumu. Çocuk Enfeksiyon Dergisi, 5(4), 132-135. 

Technical Note, Case Presentation, Research Note, etc.

1. Vaka   Takdimi,  Do   an   Murat,Bekta    Mehmet  Selçuk,OKUR   MESUT,DO   AN    EK  BE   ZEHRA,CESUR YA  AR,ÇAKSEN  HÜSEY N,ÇA  AN   EREN  (2020).   Glutarik   Asidüri  Tip   2.   Arama  Sonuçlar  Web sonuçlar Türkiye Çocuk Hastal klar Dergisi, 6(3), 171-175. 
2. Vaka Takdimi, Kaya Avni,OKUR MESUT,AKBAYRAM S  NAN,AVCU  SERHAT,AÇIKGÖZ  MEHMET,Do an Murat,AKIL  MUHAMMET   (2020).  Acute   respiratory   distress  syndromerelated   to   near  hanging:   a case report. Turkish Archives of Pediatrics, 47(4), 302-304. 
3. Vaka Takdimi,  OKUR  MESUT,KÜÇÜK ADEM,ÖZKAN  AYBARS,KAYA  MURAT,TA KIN  AL  KEMAL (2020). Rectal Foreign-Body Retained by Self-Sexual Stimulation: A Case  of a  12  Year-Old Boy.  Journal(Yay n No: 6374953)
4. Vaka Takdimi, OKUR MESUT,Bekta  Mehmet Selçuk,TEMEL HAYRETT N,ÇAKSEN HÜSEY N,AÇIKGÖZ MEHMET,SAL  ERTAN  (2020). Biotidinase  Deficiency  Accompanied  by   Diffuse   Demyelination   and Cerebral Atrophy. European Journal of General Medicine, 9(3), 197-200. 
5. Vaka   Takdimi,  OKUR   MESUT,GÜNE   CEMALETT N,Özkan    Aybars,KAYA    MURAT,OKTAY    MURAT (2020).    Tekrarlayan akci   er  enfeksiyonu nedeniyle  ba   vuran bir  bronkojenik  kist olgusu.    Abant        T p Dergisi, 2, 43-45. 
6. Vaka Takdimi, Özkan Aybars,OKUR  MESUT,KAYA MURAT,KÜÇÜK  ADEM,SARI  LYAS (2020).  Necrotic Appendix  in Amyand’s  Hernia:  A  Case  Report.  International  Journal  of Clinical  Medicine,  4, 1-3.       
7. Vaka   Takdimi,  GÜN   EMRAH,AYAZ   NUSRET,UZUN  HAKAN,OKUR   MESUT,GÖNEN                                                                                                BAK,GÜNE CEMALETT N,SOYSAL ZEYNEB,KOCABAY KENAN (2020). Nefrolitiazisin E  lik Etti  i Nadir Bir Hastane Enfeksiyonu   EtkeniSphingomonas   Paucimobilis.    Cocuk  Enfeksiyon   Dergisi,   8(3),  125-127.   
8. Editöre  Mektup, Özkan   Aybars,KATRANCI   AL  OSMAN,OKUR   MESUT,KAYA   MURAT,KÜÇÜK  ADEM (2020).   Jel yak t na ba  l derin yüz yan     geli  en bir çocuk olgu.   Turk Pediatri Arsivi, 48(4), 350-            352. 
9. Vaka Takdimi, Akgun Cihangir,Kaya  Avni,AKBAYRAM  S NAN,TUNCER O  UZ,OKUR  MESUT,ARSLAN ÜKRÜ,ÖZEN SÜLEYMAN (2020). Lökositoklastik Vaskulit ve Membrano-proliferatif Glomerulonefrit

Birlikteli i: A case study Konuralp Tip Dergisi, 5(3), 58-61. 

1. Vaka Takdimi,  ÖZKAN  AYBARS,OKUR MESUT,KAYA  MURAT,KÜÇÜK   ADEM,UZUN  HAKAN   (2020). Apandisiti  taklit eden   intestinal  non-Hodgkin lenfoma.   Ça   da  T  p  Dergisi,  4(2),   100-110.   
2. Vaka Takdimi, Kaya Avni,AKIL MUHAMMET,TEMEL  HAYRETT N,OKUR  MESUT,Do an  Murat,PEKER ERDAL,ÜNER ABDURRAHMAN,B L C SAL M (2020). Akut  Bat  n Klini  i  ile Seyreden  Brusella:  ki Olgu Sunumu. Van T p Dergisi, 20(2), 81-83. 
3. Vaka   Takdimi,  Özkan   Aybars,KAYA   MURAT,OKUR  MESUT,KOCABAY   GÖNENÇ,KOCABAY   KENAN (2020).  Ventrikülo-Peritoneal    ant  Sonrasi Masif  Asiti  Taklit Eden  DevAbdominal  Psödokist.  DÜZCE     TIP DERG S , 15(2), 52-54. 
4. Vaka Takdimi,  Kaya   Avni,OKUR  MESUT,ÜSTYOL   LOKMAN,TEMEL   HAYRETT N,ÇAKSEN   HÜSEY  N (2020).  Acute  cyanide  poisoning after  eating  apricot pits:  a case report.    Turkish Archives  of Pediatrics, 47(2), 141-142. 
5. Editöre  Mektup, Erbey  Fatih,Rüzgar  Hacer,OKUR MESUT  (2020).    Risperidona ba  l   lökopeni ve  nötropeni  geli en  7  ya  nda  bir  olgu.   Anadolu  Psikiyatri  Dergisi, 12(3),  244-244.  
6. Vaka Takdimi,  Soysal  Zeyneb,OKUR  MESUT,ERÖZ   RECEP,Gün   Emrah,KOCABAY   KENAN,Be  ir   Fahri Halit (2015). MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH  SUBCORTICAL  CYSTS WITH HOMOZYGOUS MUTATION (C.448DELC, P.LEU150 SER FSX11) ON EXON 6 OF MLC1 GENE..  Genetic   counseling (Geneva, Switzerland), 26(2), 233-6. 

Technical Note, Case Presentation, Research Note, etc.

1. Vaka Takdimi,  Özkan  Aybars,Bozkurter  Çil Asudan  Tu   çe,KAYA MURAT,Etçio   lu   nci,OKUR MESUT (2015).  Late   Presenting  Bochdalek   Hernia   With  Gastric   Perforation.   Pediatric  Emergency   Care, 31(1), 47-49. 
2. Vaka   Takdimi,  Özkan   Aybars,OKUR   MESUT,KAYA  MURAT,Büyükkaya  Ramazan,Katranc   Ali Osman,Küçük Adem (2013). An easy technique for removal  of  knotted catheter  in  the bladder: percutaneous  suprapubic   cystoscopic   intervention..     International   journal  of   clinical   and experimental medicine, 6(7), 603-5. 
3. Vaka Takdimi,  Özkan  Aybars,OKUR MESUT,KAYA   MURAT,Küçük   Adem  (2013).   A   Case  of Bronchogenic  Cyst  Mimicking Foreign  Body   Aspiration.  Pediatric   Emergency   Care,  29(7),   833-835. 
4. Vaka   Takdimi,  OKUR   MESUT,ERÖZ    RECEP,Mundlos    Stefan,  enses    Dursun    Ali,ÜLGEN   TEMEL ESRA, smailler  Zeynep  Bengül,ÖZÇEL K  DERYA (2012).   EEC  syndrome with  a  de novo  mutation    (c.953g gt  a)  on exon  7  of P63  gene:  a case report.    Genetic counseling  (Geneva,  Switzerland), 23(4), 483-5. 
5. Vaka Takdimi, Uslu Mustafa,OKUR MESUT,Gönen bak  (2012).  Low-grade Osteomyelitis  of  the Fifth Metatarsal  with  Possible Concomitant  Freiberg’s  Disease of  the  Metatarsal Head.    The  Journal of      Foot and Ankle Surgery, 51(6), 798-800. 
6. Vaka Takdimi,  Turan  Hakan,OKUR MESUT,Kaya  Ertu  rul,Gün  Emrah,Alia   ao   lu  Cihangir   (2012). Allergic  contact dermatitis  to  para-phenylenediamine  in a  tattoo:   a case report.   Cutaneous  and Ocular Toxicology, 32(2), 185-187. 
7. Vaka   Takdimi,   OKUR    MESUT,Turan    Hakan,Özkan    Aybars,Güne    Cemalettin,KOCABAY    KENAN (2012).    An extremely  rare  cause of  bruising  in children:  Autoerithrocyte  Sensitization Syndrome.  Turkish Journal of Hematology, 29(2), 201-203. 
8. Vaka Takdimi,  Öz  ahin  Mustafa,Uslu   Mustafa,  nanmaz  Erkan,OKUR   MESUT   (2012).  Bilateral Congenital Undescended Scapula (Sprengel  Deformity). American  Journal  of Physical  Medicine Rehabilitation, 91(4), 374 
9. Editöre  Mektup, Kaya  Avni,Ta   k  n  Gökmen Alpaslan,OKUR  MESUT,Bekta    Mehmet Selçuk,ÇAKSEN  HÜSEY  N (2012).  Infantile  Masturbation in   Monozygotic   Twins.  The   Journal   of  Sexual   Medicine, 9(1), 331-332. 
10. Editöre  Mektup, Kaya  Avni,OKUR  MESUT (2012).   Bee  sting in  mother  and urticarial  rash  in her    baby.. Indian pediatrics, 49(6), 499 
11. Vaka Takdimi, OKUR MESUT,Erbey Fatih,Bulut Gülay  (2011).  Phyllodes Tumor  in  a 16-Year-Old  Girl. Pediatric Hematology and Oncology, 28(5), 444-446. 
12. Vaka   Takdimi,  OKUR   MESUT,Özkan   Aybars,GÜNE  CEMALETT  N,KAYA   MURAT,KOCABAY   KENAN (2011).   Case of isolated thrombocytopenia due to cobalamin deficiency..   International journal of   hematology, 94(5), 488-90., 
13. Vaka Takdimi,  Kaya   Avni,Aç kgöz   Mehmet,ÜSTYOL   LOKMAN,Avcu  Serhat,Sal   Ertan,OKUR MESUT,ÇAKSEN HÜSEY N (2010). A case of  acute  disseminated encephalomyelitis  mimicking leukodystrophy.. The Kurume medical journal, 
14. Vaka Takdimi,  Y  lmaz Cahide,OKUR   MESUT,Geylani   Hadi,ÇAKSEN  HÜSEY  N,TUNCER  O   UZ,ATA BÜLENT  (2010).  Chronic  mercury  poisoning: Report  of  two siblings.   Indian  Journal of  Occupational  and Environmental Medicine, 14(1), 17 
15. Vaka    Takdimi,   ÇAKSEN    HÜSEY N,Bartsch    Oliver,OKUR    MESUT,TEMEL    HAYRETT N,Aç kgöz  Mehmet,Y lmaz   Cahide   (2009).  Rubinstein-Taybi   syndrome   and  CREBBP   c.201   202delTA  mutation: a  case  presenting with   varicella   meningoencephalitis..   Genetic  counseling   (Geneva,   Switzerland), 

Non-Academic Experience

2009-2010        Specialist Doctor          VAN GYNAECOLOGY AND PEDIATRIC HOSPITAL (State)

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.